You are here: Industry Insights > API

News List

Asymchem Expands Oligonucleotides Mfg. Capacity contractpharma
March 29, 2021
API facility in Tianjin, China will accommodate gram to ton production scales with capacity to accommodate 12 or more oligo process production lines.
Govt. set to introduce single-window clearance for investors by Apr15: DPIIT Secy expresspharma
March 26, 2021
The single-window portal will integrate the existing clearance systems of various central and state departments.
Pharma MSMEs seek government intervention to tackle shortage, price increase of raw materials expresspharma
March 17, 2021
Caution that if the situation continues, there could be a scarcity of medicines in the country.
C2 PHARMA Completes Multiple Regulatory Filings, Expands API Portfolio to Solidify Position as a Leading Ophthalmic API Supplier to the Pharmaceutical Industry PharmaSources.com
February 24, 2021
Luxembourg, February 23, 2021 – C2 PHARMA, a pharmaceutical group established in 2014 focused on niche active pharmaceutical ingredient (APIs), has expanded its portfolio of APIs and botanical extracts throughout 2020.
Cascade Chemistry Initiates Expansion of cGMP Manufacturing Capacity americanpharmaceuticalreview
February 23, 2021
Cascade Chemistry announced initiation of construction of new facilities designed to increase the company’s capacity to manufacture APIs (active pharmaceutical ingredients) under cGMP (current Good Manufacturing Practices standards and procedures).
Wavelength Pharmaceuticals Acquires Majority Stake in Vanamali Organics contractpharma
February 20, 2021
Wavelength Pharmaceuticals, a developer and manufacturer of active pharmaceutical ingredients (APIs), has acquired a majority stake in Vanamali Organics Pvt. Ltd. of Telangana, India.
Cascade Chemistry Begins $14M cGMP Mfg. Capacity Expansion contractpharma
February 20, 2021
Cascade Chemistry, a pharmaceutical CDMO, began construction of new facilities to increase capacity to manufacture APIs under cGMP.
Lonza Expands Solid Small Molecule Services contractpharma
February 18, 2021
To encompass all aspects of solid form screening and characterization of small molecule APIs.
TCG Lifesciences Expands Footprint to the U.S. contractpharma
February 09, 2021
TCG Lifesciences Pvt. Ltd., a company controlled by New York-based The Chatterjee Group, has expanded its operations in the U.S. with the establishment of TCG GreenChem Inc., a subsidiary of TCG Lifesciences to provide contract development and ...
Sai Life Sciences Expands Capabilities contractpharma
February 01, 2021
Sai Life Sciences, a contract research, development and manufacturing organization (CRDMO), has unveiled plans to double its headcount and expand its suite of technical capabilities at its Manchester, UK site, a center of excellence for active ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page